IDiyas

For the Inventor, By the Inventor

Durham, CT, United States of America

Ping Ge

USPTO Granted Patents = 10 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Branford, CT (US) (2001 - 2002)
  • Durham, CT (US) (2003 - 2010)

Company Filing History:

goldMedal10 out of 305 
 
Neurogen Corporation
 patents

Years Active: 2001-2010

Loading Chart...
10 patents (USPTO):
1. 7851474 - Dipiperazinyl ketones and related analogues (2010-12-14),
2. 7728009 - Thiazole amides, imidazole amides and related analogues (2010-06-01),
3. 7202250 - Substituted arylpyrazines (2007-04-10),
4. 7179807 - 5-substituted-2-arylpyrazines (2007-02-20),
5. 6995161 - Substituted arylpyrazines (2006-02-07),
6. 6887875 - 2,5-diarypyrimidine compounds (2005-05-03),
7. 6583169 - N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives (2003-06-24),
8. 6436932 - Aminoalkyl substituted pyrrolo[3,2-e] pyridine and pyrrolo[2,3-b]pyrimidine derivatives: modulators of CRF1 receptors (2002-08-20),
9. 6310063 - Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors (2001-10-30),
10. 6281237 - N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives (2001-08-28),

Title: The Innovations of Ping Ge

Introduction

Ping Ge is a notable inventor based in Durham, CT (US), recognized for his contributions to the field of pharmaceutical sciences. He holds a total of 10 patents, showcasing his innovative approach to developing compounds that can significantly impact medical treatments.

Latest Patents

Among his latest patents, Ping Ge has developed Dipiperazinyl ketones and related analogues. These compounds are designed to modulate ligand binding to histamine H3 receptors, which can be beneficial in treating various disorders in humans and animals. Additionally, he has worked on Thiazole amides, imidazole amides, and related analogues, which also target histamine H3 receptors and are particularly useful for central nervous system disorders.

Career Highlights

Ping Ge is currently associated with Neurogen Corporation, where he continues to innovate and contribute to the development of therapeutic methods. His work focuses on creating pharmaceutical compositions that can enhance the efficacy of treatments for various conditions.

Collaborations

Throughout his career, Ping Ge has collaborated with esteemed colleagues such as Raymond F Horvath and Taeyoung Yoon, further enriching his research and development efforts.

Conclusion

Ping Ge's innovative work in the pharmaceutical field, particularly in the development of compounds targeting histamine H3 receptors, highlights his significant contributions to medical science. His patents reflect a commitment to improving treatment options for both humans and animals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…